DOI: 10.1016/s0955-0674(96)80071-8. Targeting signal transduction for disease therapy

Targeting signal transduction for disease therapy

10.1016/s0955-0674(96)80071-8

Crossref journal-article

Elsevier BV

Current Opinion in Cell Biology (78)

Bibliography

Levitzki, A. (1996). Targeting signal transduction for disease therapy. Current Opinion in Cell Biology, 8(2), 239â244.

Authors 1

Alexander Levitzki (first)

References 54 Referenced 88

10.1111/j.1432-1033.1994.tb20020.x / Eur J Biochem / Signal transduction therapy by Levitzki (1994)
10.1016/0163-7258(94)90005-1 / Pharmacol Ther / Signaling pathways as targets for anticancer drug development by Powis (1994)
10.1517/13543784.3.6.577 / Exp Opin Invest Drugs / Protein tyrosine kinases as therapeutic targets in cancer chemotherapy and recent advances in the development of new inhibitors by Fry (1994)
10.1007/BF00918679 / J Clin Immunol / Monoclonal antibody therapy of human cancer: taking the HER2 protooncogene to the clinic by Shepard (1991)
10.1016/0163-7258(94)90036-1 / Pharmacol Ther / Receptor blockade with monoclonal antibodies as anti-cancer therapy by Baselga (1994)
{'key': '10.1016/S0955-0674(96)80071-8_BIB6', 'first-page': '4430', 'article-title': 'The antiproliferative effects of tyrosine kinase inhibitor tyrphostin on a human squamous cell carcinoma in vitro and in nude mice', 'volume': '51', 'author': 'Yoneda', 'year': '1991', 'journal-title': 'Cancer Res'} / Cancer Res / The antiproliferative effects of tyrosine kinase inhibitor tyrphostin on a human squamous cell carcinoma in vitro and in nude mice by Yoneda (1991)
10.1038/nm0895-792 / Nature Med / Inhibition of farnesyltransferase induces regression of mammary and salivary carcinoma in ras transgenic mice by Kohl (1995)
10.1038/379645a0 / Nature / Inhibition of recurrent human pre-B acute lymphoblastic leukemia by Jak-2 tyrosine kinase inhibitor by Meydan (1996)
10.1038/nm0695-541 / Nature Med / Inhibition of cellular ras prevents smooth muscle proliferation after vascular injury in vivo by Indolfi (1995)
{'key': '10.1016/S0955-0674(96)80071-8_BIB10', 'first-page': '3183', 'article-title': 'Ribozyme-mediated cleavage of the BCR—ABL oncogene transcript: in vitro cleavage of RNA and in vivo loss of P210 protein-kinase activity', 'volume': '8', 'author': 'Shore', 'year': '1993', 'journal-title': 'Oncogene'} / Oncogene / Ribozyme-mediated cleavage of the BCR—ABL oncogene transcript: in vitro cleavage of RNA and in vivo loss of P210 protein-kinase activity by Shore (1993)
10.1038/372642a0 / Nature / In vivo repression by a site-specific DNA-binding protein designed against an oncogenic sequence by Choo (1994)
10.1016/0958-1669(95)80111-1 / Curr Opin Biotechnol / VEGF mediated tumor angiogenesis: a new target for cancer therapy by Martiny-Baron (1995)
{'key': '10.1016/S0955-0674(96)80071-8_BIB13', 'article-title': 'Src as a target for anticancer drugs', 'author': 'Levitzki', 'year': '1996', 'journal-title': 'Anti Cancer Drug Des'} / Anti Cancer Drug Des / Src as a target for anticancer drugs by Levitzki (1996)
10.1126/science.7892601 / Science / Tyrosine kinases inhibitioin: an approach to drug development by Levitzki (1995)
10.1126/science.8066447 / Science / A specific inhibitor of the epidermal growth factor receptor tyrosine kinase by Fry (1994)
10.1073/pnas.91.6.2334 / Proc Natl Acad Sci USA / 4,5-dianilinophthalimide: a protein-tyrosine kinase inhibitor with selectivity for the epidermal growth factor receptor signal transduction pathway and potent in vivo antitumor activity by Buchdunger (1994)
10.1111/j.1432-1033.1994.1047b.x / Eur J Biochem / Epidermal growth factor dependent activation of Src family kinases by Osherov (1994)
10.1126/science.7531365 / Science / Biotherapy of B-cell precursor leukemia by targeting genistein to CD19-associated tyrosine kinases by Uckun (1995)
10.1038/362801a0 / Nature / The pathogenesis of atherosclerosis: a perspective for the 1990's by Ross (1993)
{'key': '10.1016/S0955-0674(96)80071-8_BIB20_1', 'first-page': '6106', 'article-title': 'Selective platelet-derived growth factor receptor kinase blockers reverse cis-transformation', 'volume': '54', 'author': 'Kovalenko', 'year': '1994', 'journal-title': 'Cancer Res'} / Cancer Res / Selective platelet-derived growth factor receptor kinase blockers reverse cis-transformation by Kovalenko (1994)
10.1016/0014-4827(92)90432-8 / Exp Cell Res / Inhibition of platelet derived growth factor (PDGF) induced mitogenic activity by PDGF receptor tyrosine kinase tyrphostin inhibitors by Bryckaert (1992)
{'key': '10.1016/S0955-0674(96)80071-8_BIB22_1', 'article-title': 'Controlled delivery of a tyrphostin inhibits intimal hyperplasia in rat carotid artery injury model', 'author': 'Golom', 'year': '1996', 'journal-title': 'Atherosclerosis'} / Atherosclerosis / Controlled delivery of a tyrphostin inhibits intimal hyperplasia in rat carotid artery injury model by Golom (1996)
10.1126/science.2916128 / Science / Overexpression of TGFα in psoriatic epidermis by Elder (1989)
10.1111/j.1600-0625.1995.tb00227.x / Exp Dermatol / Tyrphostins suppress the growth of psoriatic keratinocytes by Ben-Bassat (1995)
10.1126/science.2157286 / Science / Association of human Papilloma virus type 16 and 18 with p53 by Werness (1990)
10.1126/science.2537532 / Science / The human Papillomavirus-16 E7 is able to bind the retinoblastoma gene product by Dyson (1989)
10.1128/MCB.14.12.8250 / Mol Cell Biol / Targeted expression of the E6 and E7 oncogenes of human papillomavirus type 16 in the epidermis of transgenic mice elicits generalized epidermal hyperplasia involving autocrine factors by Auewarakul (1994)
10.1073/pnas.88.10.4148 / Proc Natl Acad Sci USA / Bacterial lipopolysaccharide stimulates protein tyrosine phosphorylation in macrophages by Weinstein (1991)
10.1016/S0021-9258(19)36840-1 / J Biol Chem / Lipopolysaccharide induces activation of CD14 associated protein kinase p53/56lyn by Stefanova (1993)
10.1126/science.8191285 / Science / Prevention of LPS-induced lethal toxicity by tyrosine kinase blockers by Novogrodsky (1994)
10.1093/infdis/173.4.927 / J Infect Dis / Late administration of lipophylic tyrphostins prevents lipopolysaccharide and E. coli lethal toxicity by Vanichkin (1996)
10.1006/bbrc.1995.2491 / Biochem Biophys Res Commun / Tumor necrosis factor alpha increases tyrosine phosphorylation of a 23-kDa nuclear protein in U937 cells through ceramide signaling pathway by Ji (1995)
10.1016/0092-8674(94)90308-5 / Cell / Farnesyl transferase inhibitors: Ras research yields a potential cancer therapeutic by Gibbs (1994)
{'key': '10.1016/S0955-0674(96)80071-8_BIB34', 'first-page': '4682', 'article-title': 'Ras oncogenes and human cancer', 'volume': '49', 'author': 'Bos', 'year': '1989', 'journal-title': 'Cancer Res'} / Cancer Res / Ras oncogenes and human cancer by Bos (1989)
10.1073/pnas.90.12.5564 / Proc Natl Acad Sci USA / Residues crucial for Ras interaction with GDP—GTP exchangers by Segal (1993)
10.1016/0958-1669(95)80110-3 / Curr Opin Biotechnol / The Rac and Rho pathways as a source for drug targets for Ras-mediated malignancies by Symons (1995)
{'key': '10.1016/S0955-0674(96)80071-8_BIB37', 'first-page': '545', 'article-title': 'Mutations of cell cycle regulators. Biological and clinical implications for human neoplasia', 'volume': '147', 'author': 'Cordon-Cardo', 'year': '1995', 'journal-title': 'Am J Pathol'} / Am J Pathol / Mutations of cell cycle regulators. Biological and clinical implications for human neoplasia by Cordon-Cardo (1995)
10.1111/j.1432-1033.1994.00771.x / Eur J Biochem / Inhibition of cyclin dependent kinases by purine analogs by Vesely (1994)
{'key': '10.1016/S0955-0674(96)80071-8_BIB39', 'first-page': '2425', 'article-title': 'Butyrolactone-1, a selective inhibitor of cdk2 and cdc 2 kinase', 'volume': '8', 'author': 'Kitagawa', 'year': '1993', 'journal-title': 'Oncogene'} / Oncogene / Butyrolactone-1, a selective inhibitor of cdk2 and cdc 2 kinase by Kitagawa (1993)
10.1006/bbrc.1994.1742 / Biochem Biophys Res Commun / Potent inhibition of cdc2 kinase by the flavanoid L86-8275 by Losiewicz (1994)
{'key': '10.1016/S0955-0674(96)80071-8_BIB41', 'first-page': '795', 'article-title': 'Tamoxifen therapy in breast cancer control worldwide', 'volume': '71', 'author': 'Love', 'year': '1993', 'journal-title': 'Bull World Health Organ'} / Bull World Health Organ / Tamoxifen therapy in breast cancer control worldwide by Love (1993)
{'key': '10.1016/S0955-0674(96)80071-8_BIB42', 'first-page': '3867', 'article-title': 'A potent specific pure antiestrogen with clinical potential', 'volume': '51', 'author': 'Wakeling', 'year': '1991', 'journal-title': 'Cancer Res'} / Cancer Res / A potent specific pure antiestrogen with clinical potential by Wakeling (1991)
10.1126/science.270.5234.286 / Science / Immunosuppression by glucocorticoids: inhibition of NF-κB activity through induction of 1 κ B synthesis by Auphan (1995)
10.1074/jbc.270.24.14255 / J Biol Chem / Inhibition of nuclear translocation of transcription factor NF-kappa B by a synthetic peptide containing a cell membrane-permeable motif and nuclear localization sequence by Lin (1995)
10.1016/S0960-9822(95)00058-3 / Curr Biol / A small peptide inhibitor of DNA replication defines the site of interaction between the cyclin-dependent kinase inhibitor p21WAF1 and proliferating cell nuclear antigen by Warbrick (1995)
10.1016/0378-1119(92)90727-7 / Gene / Ribozymes designed to inhibit transformation of NIH3T3 cells by the activated c-Ha-ras gene by Koizumi (1992)
10.1093/jnci/85.16.1327 / J Natl Cancer Inst / Antitumor effects of doxorublan in combination with anti-EGF receptor monoclonal antibodies by Besalga (1993)
{'key': '10.1016/S0955-0674(96)80071-8_BIB48', 'article-title': 'Enhancement of chemosensitivity by tyrphostin AG 825 in high p185neu expressing non-small cell lung cancer cells', 'author': 'Tsai', 'year': '1996', 'journal-title': 'Cancer Res'} / Cancer Res / Enhancement of chemosensitivity by tyrphostin AG 825 in high p185neu expressing non-small cell lung cancer cells by Tsai (1996)
{'key': '10.1016/S0955-0674(96)80071-8_BIB49', 'first-page': '2419', 'article-title': "Wortmannin a potent and selective inhibitor of phosphatidylinositol-3'-kinase", 'volume': '1', 'author': 'Powis', 'year': '1994', 'journal-title': 'Cancer Res'} / Cancer Res / Wortmannin a potent and selective inhibitor of phosphatidylinositol-3'-kinase by Powis (1994)
10.1042/bj2960297 / Biochem J / Wortmannin is a potent phosphatidylinositol 3-kinase inhibitor: the role of phosphatidylinositol 3,4,5-trisphosphate in neutrophil responses by Arcaro (1993)
10.1073/pnas.92.17.7686 / Proc Natl Acad Sci USA / A synthetic inhibitor of the mitogen-activated protein kinase cascade by Dudley (1995)
{'key': '10.1016/S0955-0674(96)80071-8_BIB52', 'first-page': '301', 'article-title': 'A phase I study of intravenous bryostatin 1 in patients with advanced cancer', 'volume': '155', 'author': 'Prendville', 'year': '1993', 'journal-title': 'J Cell Physiol'} / J Cell Physiol / A phase I study of intravenous bryostatin 1 in patients with advanced cancer by Prendville (1993)
10.1073/pnas.92.7.2558 / Proc Natl Acad Sci USA / Selective inhibition of the platelet-derived growth factor signal transduction pathway by a protein-tyrosine kinase inhibitor of the 2-phenylaminopyrimidine class by Buchdunger (1995)
10.1182/blood.V82.12.3524.3524 / Blood / Tyrphostin induced inhibition of p210bcr—abl tyrosine kinase activity induces K562 to differentiate by Anafi (1993)

Dates

Type	When
Created	23 years, 1 month ago (July 25, 2002, 2:32 a.m.)
Deposited	4 years, 3 months ago (May 4, 2021, 4:44 a.m.)
Indexed	2 months ago (June 27, 2025, 3:44 p.m.)
Issued	29 years, 5 months ago (April 1, 1996)
Published	29 years, 5 months ago (April 1, 1996)
Published Print	29 years, 5 months ago (April 1, 1996)

Funders 0

None

BibTeX

@article{Levitzki_1996, title={Targeting signal transduction for disease therapy}, volume={8}, ISSN={0955-0674}, url={http://dx.doi.org/10.1016/s0955-0674(96)80071-8}, DOI={10.1016/s0955-0674(96)80071-8}, number={2}, journal={Current Opinion in Cell Biology}, publisher={Elsevier BV}, author={Levitzki, Alexander}, year={1996}, month=apr, pages={239–244} }

JSON

{
  "indexed": {
    "date-parts": [
      [
        2025,
        6,
        27
      ]
    ],
    "date-time": "2025-06-27T19:44:04Z",
    "timestamp": 1751053444087
  },
  "reference-count": 54,
  "publisher": "Elsevier BV",
  "issue": "2",
  "license": [
    {
      "start": {
        "date-parts": [
          [
            1996,
            4,
            1
          ]
        ],
        "date-time": "1996-04-01T00:00:00Z",
        "timestamp": 828316800000
      },
      "content-version": "tdm",
      "delay-in-days": 0,
      "URL": "https://www.elsevier.com/tdm/userlicense/1.0/"
    }
  ],
  "content-domain": {
    "domain": [],
    "crossmark-restriction": false
  },
  "published-print": {
    "date-parts": [
      [
        1996,
        4
      ]
    ]
  },
  "DOI": "10.1016/s0955-0674(96)80071-8",
  "type": "journal-article",
  "created": {
    "date-parts": [
      [
        2002,
        7,
        25
      ]
    ],
    "date-time": "2002-07-25T06:32:55Z",
    "timestamp": 1027578775000
  },
  "page": "239-244",
  "source": "Crossref",
  "is-referenced-by-count": 88,
  "title": "Targeting signal transduction for disease therapy",
  "prefix": "10.1016",
  "volume": "8",
  "author": [
    {
      "given": "Alexander",
      "family": "Levitzki",
      "sequence": "first",
      "affiliation": []
    }
  ],
  "member": "78",
  "reference": [
    {
      "key": "10.1016/S0955-0674(96)80071-8_BIB1",
      "doi-asserted-by": "crossref",
      "first-page": "1",
      "DOI": "10.1111/j.1432-1033.1994.tb20020.x",
      "article-title": "Signal transduction therapy",
      "volume": "226",
      "author": "Levitzki",
      "year": "1994",
      "journal-title": "Eur J Biochem"
    },
    {
      "key": "10.1016/S0955-0674(96)80071-8_BIB2",
      "doi-asserted-by": "crossref",
      "first-page": "57",
      "DOI": "10.1016/0163-7258(94)90005-1",
      "article-title": "Signaling pathways as targets for anticancer drug development",
      "volume": "62",
      "author": "Powis",
      "year": "1994",
      "journal-title": "Pharmacol Ther"
    },
    {
      "key": "10.1016/S0955-0674(96)80071-8_BIB3",
      "doi-asserted-by": "crossref",
      "first-page": "577",
      "DOI": "10.1517/13543784.3.6.577",
      "article-title": "Protein tyrosine kinases as therapeutic targets in cancer chemotherapy and recent advances in the development of new inhibitors",
      "volume": "3",
      "author": "Fry",
      "year": "1994",
      "journal-title": "Exp Opin Invest Drugs"
    },
    {
      "key": "10.1016/S0955-0674(96)80071-8_BIB4",
      "doi-asserted-by": "crossref",
      "first-page": "117",
      "DOI": "10.1007/BF00918679",
      "article-title": "Monoclonal antibody therapy of human cancer: taking the HER2 protooncogene to the clinic",
      "volume": "11",
      "author": "Shepard",
      "year": "1991",
      "journal-title": "J Clin Immunol"
    },
    {
      "key": "10.1016/S0955-0674(96)80071-8_BIB5",
      "doi-asserted-by": "crossref",
      "first-page": "127",
      "DOI": "10.1016/0163-7258(94)90036-1",
      "article-title": "Receptor blockade with monoclonal antibodies as anti-cancer therapy",
      "volume": "64",
      "author": "Baselga",
      "year": "1994",
      "journal-title": "Pharmacol Ther"
    },
    {
      "key": "10.1016/S0955-0674(96)80071-8_BIB6",
      "first-page": "4430",
      "article-title": "The antiproliferative effects of tyrosine kinase inhibitor tyrphostin on a human squamous cell carcinoma in vitro and in nude mice",
      "volume": "51",
      "author": "Yoneda",
      "year": "1991",
      "journal-title": "Cancer Res"
    },
    {
      "key": "10.1016/S0955-0674(96)80071-8_BIB7_1",
      "doi-asserted-by": "crossref",
      "first-page": "792",
      "DOI": "10.1038/nm0895-792",
      "article-title": "Inhibition of farnesyltransferase induces regression of mammary and salivary carcinoma in ras transgenic mice",
      "volume": "1",
      "author": "Kohl",
      "year": "1995",
      "journal-title": "Nature Med"
    },
    {
      "key": "10.1016/S0955-0674(96)80071-8_BIB8_1",
      "doi-asserted-by": "crossref",
      "first-page": "645",
      "DOI": "10.1038/379645a0",
      "article-title": "Inhibition of recurrent human pre-B acute lymphoblastic leukemia by Jak-2 tyrosine kinase inhibitor",
      "volume": "379",
      "author": "Meydan",
      "year": "1996",
      "journal-title": "Nature"
    },
    {
      "key": "10.1016/S0955-0674(96)80071-8_BIB9_1",
      "doi-asserted-by": "crossref",
      "first-page": "541",
      "DOI": "10.1038/nm0695-541",
      "article-title": "Inhibition of cellular ras prevents smooth muscle proliferation after vascular injury in vivo",
      "volume": "1",
      "author": "Indolfi",
      "year": "1995",
      "journal-title": "Nature Med"
    },
    {
      "key": "10.1016/S0955-0674(96)80071-8_BIB10",
      "first-page": "3183",
      "article-title": "Ribozyme-mediated cleavage of the BCR\u2014ABL oncogene transcript: in vitro cleavage of RNA and in vivo loss of P210 protein-kinase activity",
      "volume": "8",
      "author": "Shore",
      "year": "1993",
      "journal-title": "Oncogene"
    },
    {
      "key": "10.1016/S0955-0674(96)80071-8_BIB11_1",
      "doi-asserted-by": "crossref",
      "first-page": "642",
      "DOI": "10.1038/372642a0",
      "article-title": "In vivo repression by a site-specific DNA-binding protein designed against an oncogenic sequence",
      "volume": "372",
      "author": "Choo",
      "year": "1994",
      "journal-title": "Nature"
    },
    {
      "key": "10.1016/S0955-0674(96)80071-8_BIB12",
      "doi-asserted-by": "crossref",
      "first-page": "675",
      "DOI": "10.1016/0958-1669(95)80111-1",
      "article-title": "VEGF mediated tumor angiogenesis: a new target for cancer therapy",
      "volume": "6",
      "author": "Martiny-Baron",
      "year": "1995",
      "journal-title": "Curr Opin Biotechnol"
    },
    {
      "key": "10.1016/S0955-0674(96)80071-8_BIB13",
      "article-title": "Src as a target for anticancer drugs",
      "author": "Levitzki",
      "year": "1996",
      "journal-title": "Anti Cancer Drug Des"
    },
    {
      "key": "10.1016/S0955-0674(96)80071-8_BIB14_1",
      "doi-asserted-by": "crossref",
      "first-page": "1782",
      "DOI": "10.1126/science.7892601",
      "article-title": "Tyrosine kinases inhibitioin: an approach to drug development",
      "volume": "267",
      "author": "Levitzki",
      "year": "1995",
      "journal-title": "Science"
    },
    {
      "key": "10.1016/S0955-0674(96)80071-8_BIB15",
      "doi-asserted-by": "crossref",
      "first-page": "1093",
      "DOI": "10.1126/science.8066447",
      "article-title": "A specific inhibitor of the epidermal growth factor receptor tyrosine kinase",
      "volume": "9",
      "author": "Fry",
      "year": "1994",
      "journal-title": "Science"
    },
    {
      "key": "10.1016/S0955-0674(96)80071-8_BIB16",
      "doi-asserted-by": "crossref",
      "first-page": "2334",
      "DOI": "10.1073/pnas.91.6.2334",
      "article-title": "4,5-dianilinophthalimide: a protein-tyrosine kinase inhibitor with selectivity for the epidermal growth factor receptor signal transduction pathway and potent in vivo antitumor activity",
      "volume": "91",
      "author": "Buchdunger",
      "year": "1994",
      "journal-title": "Proc Natl Acad Sci USA"
    },
    {
      "key": "10.1016/S0955-0674(96)80071-8_BIB17_1",
      "doi-asserted-by": "crossref",
      "first-page": "1047",
      "DOI": "10.1111/j.1432-1033.1994.1047b.x",
      "article-title": "Epidermal growth factor dependent activation of Src family kinases",
      "volume": "225",
      "author": "Osherov",
      "year": "1994",
      "journal-title": "Eur J Biochem"
    },
    {
      "key": "10.1016/S0955-0674(96)80071-8_BIB18_1",
      "doi-asserted-by": "crossref",
      "first-page": "886",
      "DOI": "10.1126/science.7531365",
      "article-title": "Biotherapy of B-cell precursor leukemia by targeting genistein to CD19-associated tyrosine kinases",
      "volume": "267",
      "author": "Uckun",
      "year": "1995",
      "journal-title": "Science"
    },
    {
      "key": "10.1016/S0955-0674(96)80071-8_BIB19",
      "doi-asserted-by": "crossref",
      "first-page": "801",
      "DOI": "10.1038/362801a0",
      "article-title": "The pathogenesis of atherosclerosis: a perspective for the 1990's",
      "volume": "302",
      "author": "Ross",
      "year": "1993",
      "journal-title": "Nature"
    },
    {
      "key": "10.1016/S0955-0674(96)80071-8_BIB20_1",
      "first-page": "6106",
      "article-title": "Selective platelet-derived growth factor receptor kinase blockers reverse cis-transformation",
      "volume": "54",
      "author": "Kovalenko",
      "year": "1994",
      "journal-title": "Cancer Res"
    },
    {
      "key": "10.1016/S0955-0674(96)80071-8_BIB21",
      "doi-asserted-by": "crossref",
      "first-page": "255",
      "DOI": "10.1016/0014-4827(92)90432-8",
      "article-title": "Inhibition of platelet derived growth factor (PDGF) induced mitogenic activity by PDGF receptor tyrosine kinase tyrphostin inhibitors",
      "volume": "199",
      "author": "Bryckaert",
      "year": "1992",
      "journal-title": "Exp Cell Res"
    },
    {
      "key": "10.1016/S0955-0674(96)80071-8_BIB22_1",
      "article-title": "Controlled delivery of a tyrphostin inhibits intimal hyperplasia in rat carotid artery injury model",
      "author": "Golom",
      "year": "1996",
      "journal-title": "Atherosclerosis"
    },
    {
      "key": "10.1016/S0955-0674(96)80071-8_BIB23",
      "doi-asserted-by": "crossref",
      "first-page": "670",
      "DOI": "10.1126/science.2916128",
      "article-title": "Overexpression of TGF\u03b1 in psoriatic epidermis",
      "volume": "243",
      "author": "Elder",
      "year": "1989",
      "journal-title": "Science"
    },
    {
      "key": "10.1016/S0955-0674(96)80071-8_BIB24_1",
      "doi-asserted-by": "crossref",
      "first-page": "82",
      "DOI": "10.1111/j.1600-0625.1995.tb00227.x",
      "article-title": "Tyrphostins suppress the growth of psoriatic keratinocytes",
      "volume": "4",
      "author": "Ben-Bassat",
      "year": "1995",
      "journal-title": "Exp Dermatol"
    },
    {
      "key": "10.1016/S0955-0674(96)80071-8_BIB25",
      "doi-asserted-by": "crossref",
      "first-page": "76",
      "DOI": "10.1126/science.2157286",
      "article-title": "Association of human Papilloma virus type 16 and 18 with p53",
      "volume": "248",
      "author": "Werness",
      "year": "1990",
      "journal-title": "Science"
    },
    {
      "key": "10.1016/S0955-0674(96)80071-8_BIB26",
      "doi-asserted-by": "crossref",
      "first-page": "934",
      "DOI": "10.1126/science.2537532",
      "article-title": "The human Papillomavirus-16 E7 is able to bind the retinoblastoma gene product",
      "volume": "243",
      "author": "Dyson",
      "year": "1989",
      "journal-title": "Science"
    },
    {
      "key": "10.1016/S0955-0674(96)80071-8_BIB27",
      "doi-asserted-by": "crossref",
      "first-page": "8250",
      "DOI": "10.1128/MCB.14.12.8250",
      "article-title": "Targeted expression of the E6 and E7 oncogenes of human papillomavirus type 16 in the epidermis of transgenic mice elicits generalized epidermal hyperplasia involving autocrine factors",
      "volume": "14",
      "author": "Auewarakul",
      "year": "1994",
      "journal-title": "Mol Cell Biol"
    },
    {
      "key": "10.1016/S0955-0674(96)80071-8_BIB28",
      "doi-asserted-by": "crossref",
      "first-page": "4148",
      "DOI": "10.1073/pnas.88.10.4148",
      "article-title": "Bacterial lipopolysaccharide stimulates protein tyrosine phosphorylation in macrophages",
      "volume": "88",
      "author": "Weinstein",
      "year": "1991",
      "journal-title": "Proc Natl Acad Sci USA"
    },
    {
      "key": "10.1016/S0955-0674(96)80071-8_BIB29",
      "doi-asserted-by": "crossref",
      "first-page": "20725",
      "DOI": "10.1016/S0021-9258(19)36840-1",
      "article-title": "Lipopolysaccharide induces activation of CD14 associated protein kinase p53/56lyn",
      "volume": "268",
      "author": "Stefanova",
      "year": "1993",
      "journal-title": "J Biol Chem"
    },
    {
      "key": "10.1016/S0955-0674(96)80071-8_BIB30",
      "doi-asserted-by": "crossref",
      "first-page": "1319",
      "DOI": "10.1126/science.8191285",
      "article-title": "Prevention of LPS-induced lethal toxicity by tyrosine kinase blockers",
      "volume": "264",
      "author": "Novogrodsky",
      "year": "1994",
      "journal-title": "Science"
    },
    {
      "key": "10.1016/S0955-0674(96)80071-8_BIB31",
      "doi-asserted-by": "crossref",
      "DOI": "10.1093/infdis/173.4.927",
      "article-title": "Late administration of lipophylic tyrphostins prevents lipopolysaccharide and E. coli lethal toxicity",
      "author": "Vanichkin",
      "year": "1996",
      "journal-title": "J Infect Dis"
    },
    {
      "key": "10.1016/S0955-0674(96)80071-8_BIB32",
      "doi-asserted-by": "crossref",
      "first-page": "489",
      "DOI": "10.1006/bbrc.1995.2491",
      "article-title": "Tumor necrosis factor alpha increases tyrosine phosphorylation of a 23-kDa nuclear protein in U937 cells through ceramide signaling pathway",
      "volume": "215",
      "author": "Ji",
      "year": "1995",
      "journal-title": "Biochem Biophys Res Commun"
    },
    {
      "key": "10.1016/S0955-0674(96)80071-8_BIB33",
      "doi-asserted-by": "crossref",
      "first-page": "175",
      "DOI": "10.1016/0092-8674(94)90308-5",
      "article-title": "Farnesyl transferase inhibitors: Ras research yields a potential cancer therapeutic",
      "volume": "77",
      "author": "Gibbs",
      "year": "1994",
      "journal-title": "Cell"
    },
    {
      "key": "10.1016/S0955-0674(96)80071-8_BIB34",
      "first-page": "4682",
      "article-title": "Ras oncogenes and human cancer",
      "volume": "49",
      "author": "Bos",
      "year": "1989",
      "journal-title": "Cancer Res"
    },
    {
      "key": "10.1016/S0955-0674(96)80071-8_BIB35",
      "doi-asserted-by": "crossref",
      "first-page": "5564",
      "DOI": "10.1073/pnas.90.12.5564",
      "article-title": "Residues crucial for Ras interaction with GDP\u2014GTP exchangers",
      "volume": "90",
      "author": "Segal",
      "year": "1993",
      "journal-title": "Proc Natl Acad Sci USA"
    },
    {
      "key": "10.1016/S0955-0674(96)80071-8_BIB36",
      "doi-asserted-by": "crossref",
      "first-page": "668",
      "DOI": "10.1016/0958-1669(95)80110-3",
      "article-title": "The Rac and Rho pathways as a source for drug targets for Ras-mediated malignancies",
      "volume": "6",
      "author": "Symons",
      "year": "1995",
      "journal-title": "Curr Opin Biotechnol"
    },
    {
      "key": "10.1016/S0955-0674(96)80071-8_BIB37",
      "first-page": "545",
      "article-title": "Mutations of cell cycle regulators. Biological and clinical implications for human neoplasia",
      "volume": "147",
      "author": "Cordon-Cardo",
      "year": "1995",
      "journal-title": "Am J Pathol"
    },
    {
      "key": "10.1016/S0955-0674(96)80071-8_BIB38",
      "doi-asserted-by": "crossref",
      "first-page": "771",
      "DOI": "10.1111/j.1432-1033.1994.00771.x",
      "article-title": "Inhibition of cyclin dependent kinases by purine analogs",
      "volume": "224",
      "author": "Vesely",
      "year": "1994",
      "journal-title": "Eur J Biochem"
    },
    {
      "key": "10.1016/S0955-0674(96)80071-8_BIB39",
      "first-page": "2425",
      "article-title": "Butyrolactone-1, a selective inhibitor of cdk2 and cdc 2 kinase",
      "volume": "8",
      "author": "Kitagawa",
      "year": "1993",
      "journal-title": "Oncogene"
    },
    {
      "key": "10.1016/S0955-0674(96)80071-8_BIB40",
      "doi-asserted-by": "crossref",
      "first-page": "589",
      "DOI": "10.1006/bbrc.1994.1742",
      "article-title": "Potent inhibition of cdc2 kinase by the flavanoid L86-8275",
      "volume": "201",
      "author": "Losiewicz",
      "year": "1994",
      "journal-title": "Biochem Biophys Res Commun"
    },
    {
      "key": "10.1016/S0955-0674(96)80071-8_BIB41",
      "first-page": "795",
      "article-title": "Tamoxifen therapy in breast cancer control worldwide",
      "volume": "71",
      "author": "Love",
      "year": "1993",
      "journal-title": "Bull World Health Organ"
    },
    {
      "key": "10.1016/S0955-0674(96)80071-8_BIB42",
      "first-page": "3867",
      "article-title": "A potent specific pure antiestrogen with clinical potential",
      "volume": "51",
      "author": "Wakeling",
      "year": "1991",
      "journal-title": "Cancer Res"
    },
    {
      "key": "10.1016/S0955-0674(96)80071-8_BIB43",
      "doi-asserted-by": "crossref",
      "first-page": "286",
      "DOI": "10.1126/science.270.5234.286",
      "article-title": "Immunosuppression by glucocorticoids: inhibition of NF-\u03baB activity through induction of 1 \u03ba B synthesis",
      "volume": "270",
      "author": "Auphan",
      "year": "1995",
      "journal-title": "Science"
    },
    {
      "key": "10.1016/S0955-0674(96)80071-8_BIB44",
      "doi-asserted-by": "crossref",
      "first-page": "14255",
      "DOI": "10.1074/jbc.270.24.14255",
      "article-title": "Inhibition of nuclear translocation of transcription factor NF-kappa B by a synthetic peptide containing a cell membrane-permeable motif and nuclear localization sequence",
      "volume": "270",
      "author": "Lin",
      "year": "1995",
      "journal-title": "J Biol Chem"
    },
    {
      "key": "10.1016/S0955-0674(96)80071-8_BIB45",
      "doi-asserted-by": "crossref",
      "first-page": "275",
      "DOI": "10.1016/S0960-9822(95)00058-3",
      "article-title": "A small peptide inhibitor of DNA replication defines the site of interaction between the cyclin-dependent kinase inhibitor p21WAF1 and proliferating cell nuclear antigen",
      "volume": "5",
      "author": "Warbrick",
      "year": "1995",
      "journal-title": "Curr Biol"
    },
    {
      "key": "10.1016/S0955-0674(96)80071-8_BIB46",
      "doi-asserted-by": "crossref",
      "first-page": "179",
      "DOI": "10.1016/0378-1119(92)90727-7",
      "article-title": "Ribozymes designed to inhibit transformation of NIH3T3 cells by the activated c-Ha-ras gene",
      "volume": "17",
      "author": "Koizumi",
      "year": "1992",
      "journal-title": "Gene"
    },
    {
      "key": "10.1016/S0955-0674(96)80071-8_BIB47",
      "doi-asserted-by": "crossref",
      "first-page": "1327",
      "DOI": "10.1093/jnci/85.16.1327",
      "article-title": "Antitumor effects of doxorublan in combination with anti-EGF receptor monoclonal antibodies",
      "volume": "85",
      "author": "Besalga",
      "year": "1993",
      "journal-title": "J Natl Cancer Inst"
    },
    {
      "key": "10.1016/S0955-0674(96)80071-8_BIB48",
      "article-title": "Enhancement of chemosensitivity by tyrphostin AG 825 in high p185neu expressing non-small cell lung cancer cells",
      "author": "Tsai",
      "year": "1996",
      "journal-title": "Cancer Res"
    },
    {
      "key": "10.1016/S0955-0674(96)80071-8_BIB49",
      "first-page": "2419",
      "article-title": "Wortmannin a potent and selective inhibitor of phosphatidylinositol-3'-kinase",
      "volume": "1",
      "author": "Powis",
      "year": "1994",
      "journal-title": "Cancer Res"
    },
    {
      "key": "10.1016/S0955-0674(96)80071-8_BIB50",
      "doi-asserted-by": "crossref",
      "first-page": "297",
      "DOI": "10.1042/bj2960297",
      "article-title": "Wortmannin is a potent phosphatidylinositol 3-kinase inhibitor: the role of phosphatidylinositol 3,4,5-trisphosphate in neutrophil responses",
      "volume": "96",
      "author": "Arcaro",
      "year": "1993",
      "journal-title": "Biochem J"
    },
    {
      "key": "10.1016/S0955-0674(96)80071-8_BIB51_1",
      "doi-asserted-by": "crossref",
      "first-page": "7686",
      "DOI": "10.1073/pnas.92.17.7686",
      "article-title": "A synthetic inhibitor of the mitogen-activated protein kinase cascade",
      "volume": "92",
      "author": "Dudley",
      "year": "1995",
      "journal-title": "Proc Natl Acad Sci USA"
    },
    {
      "key": "10.1016/S0955-0674(96)80071-8_BIB52",
      "first-page": "301",
      "article-title": "A phase I study of intravenous bryostatin 1 in patients with advanced cancer",
      "volume": "155",
      "author": "Prendville",
      "year": "1993",
      "journal-title": "J Cell Physiol"
    },
    {
      "key": "10.1016/S0955-0674(96)80071-8_BIB53",
      "doi-asserted-by": "crossref",
      "first-page": "2558",
      "DOI": "10.1073/pnas.92.7.2558",
      "article-title": "Selective inhibition of the platelet-derived growth factor signal transduction pathway by a protein-tyrosine kinase inhibitor of the 2-phenylaminopyrimidine class",
      "volume": "92",
      "author": "Buchdunger",
      "year": "1995",
      "journal-title": "Proc Natl Acad Sci USA"
    },
    {
      "key": "10.1016/S0955-0674(96)80071-8_BIB54",
      "doi-asserted-by": "crossref",
      "first-page": "3524",
      "DOI": "10.1182/blood.V82.12.3524.3524",
      "article-title": "Tyrphostin induced inhibition of p210bcr\u2014abl tyrosine kinase activity induces K562 to differentiate",
      "volume": "82",
      "author": "Anafi",
      "year": "1993",
      "journal-title": "Blood"
    }
  ],
  "container-title": "Current Opinion in Cell Biology",
  "original-title": [],
  "language": "en",
  "link": [
    {
      "URL": "https://api.elsevier.com/content/article/PII:S0955067496800718?httpAccept=text/xml",
      "content-type": "text/xml",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://api.elsevier.com/content/article/PII:S0955067496800718?httpAccept=text/plain",
      "content-type": "text/plain",
      "content-version": "vor",
      "intended-application": "text-mining"
    }
  ],
  "deposited": {
    "date-parts": [
      [
        2021,
        5,
        4
      ]
    ],
    "date-time": "2021-05-04T08:44:44Z",
    "timestamp": 1620117884000
  },
  "score": 1,
  "resource": {
    "primary": {
      "URL": "https://linkinghub.elsevier.com/retrieve/pii/S0955067496800718"
    }
  },
  "subtitle": [],
  "short-title": [],
  "issued": {
    "date-parts": [
      [
        1996,
        4
      ]
    ]
  },
  "references-count": 54,
  "journal-issue": {
    "issue": "2",
    "published-print": {
      "date-parts": [
        [
          1996,
          4
        ]
      ]
    }
  },
  "alternative-id": [
    "S0955067496800718"
  ],
  "URL": "http://dx.doi.org/10.1016/S0955-0674(96)80071-8",
  "relation": {},
  "ISSN": [
    "0955-0674"
  ],
  "subject": [],
  "container-title-short": "Current Opinion in Cell Biology",
  "published": {
    "date-parts": [
      [
        1996,
        4
      ]
    ]
  }
}